Report | SEA Semiconductor Strategic - Leaderboard

Chinese gene sequencing developer Axbio closes Series B round at nearly $100m

Chinese gene sequencing developer Axbio closes Series B round at nearly $100m

Axbio's fourth-generation sequencer AXP100. Source: Axbio

20 June, 2022

AstraZeneca-CICC Investment Fund Axbio gene sequencing NGS Yunfeng Capital

Printed by Unregistered user on Thu, 24 Jul 2025 17:37:49 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Chinese genome sequencing firm QitanTech bags $63m co-led by GL Ventures, CDH

Singapore's Temasek backs DNA sequencing firm Oxford Nanopore’s $271m funding

Read more from Greater China

Nvidia’s AI chips widely available in China black market despite US curbs: report

Global sovereign wealth funds bullish on China again: Invesco